Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 10,185 | 9,589 | 13,876 | 13,561 | 12,475 |
| Operating Income | -10,185 | -9,589 | -13,876 | -13,561 | -12,475 |
| Interest Expense | 679 | 697 | 858 | 950 | 953 |
| Other Income | 311 | 456 | 5,593 | 746 | 828 |
| Pre-tax Income | -10,553 | -9,830 | -9,141 | -13,765 | -12,600 |
| Net Income Continuous | -10,553 | -9,830 | -9,141 | -13,765 | -12,600 |
| Net Income | $-10,553 | $-9,830 | $-9,141 | $-13,765 | $-12,600 |
| EPS Basic Total Ops | -0.27 | -0.25 | -0.23 | -0.35 | -0.33 |
| EPS Basic Continuous Ops | -0.27 | -0.25 | -0.23 | -0.36 | -0.33 |
| EPS Diluted Total Ops | -0.27 | -0.25 | -0.23 | -0.35 | -0.33 |
| EPS Diluted Continuous Ops | -0.27 | -0.25 | -0.23 | -0.36 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.25 | -0.23 | -0.35 | -0.33 |
| EBITDA(a) | $-10,200 | $-9,716 | $-14,103 | $-13,913 | $-12,865 |